Cubist Systematic Strategies’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,800
Closed -$131K 3866
2023
Q4
$131K Sell
8,800
-29,800
-77% -$338K ﹤0.01% 3116
2023
Q3
$434K Buy
38,600
+8,700
+29% +$101K ﹤0.01% 2395
2023
Q2
$301K Sell
29,900
-193,400
-87% -$1.79M ﹤0.01% 2633
2023
Q1
$2.1M Buy
223,300
+86,300
+63% +$1.02M 0.01% 1639
2022
Q4
$1.67M Buy
137,000
+117,300
+595% +$1.46M 0.01% 2006
2022
Q3
$244K Buy
+19,700
New +$344K ﹤0.01% 3636

Other funds holding ELAN

Cubist Systematic Strategies's ELAN Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 48,252 shares — an estimated $709K sold.

Cubist Systematic Strategies first reported a position in ELAN in Q3 2018 and held it in 21 quarters. The position peaked at $18.3M in Q2 2021. 393 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 48,252 Elanco Animal Health shares in Q4 2024, an estimated $709K.
  • Cubist Systematic Strategies first reported a position in Elanco Animal Health in Q3 2018 and held it in 21 quarters.
  • Cubist Systematic Strategies's Elanco Animal Health position peaked at $18.3M in Q2 2021.
  • 393 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.